The agreement comes after Dechra Pharmaceuticals issued a profit warning last month. : The Northwich-based vet products group has been in talks since April over the deal which, if backed by shareholders, would be one of the biggest take-private moves in the UK so far this year. The company floated on the London Stock Exchange in 2000 with an equity capitalisation of £60m. It now has operations in 26 countries and almost 2,500 employees.